DexCom (NASDAQ:DXCM – Get Free Report) had its price target increased by equities researchers at Citigroup from $101.00 to ...

allowing real-time access and analysis of blood glucose values from the Dexcom G6 and G7 Continuous Glucose Monitors. Achieving these goals will result in a fully functional mobile app capable of ...

The first app integration resulting from the ... DXCM’s top-line growth going forward. In June, DexCom announced the integration of its G6 CGM system with Insulet’s Omnipod 5 Automated Insulin ...

DexCom specializes in continuous glucose monitoring systems, primarily focusing on individuals managing diabetes. Its innovative CGM systems, like the G6 and the newer G7, offer real-time glucose ...